Wordt geladen...
Delivering on the promise: PARP inhibition as targeted anti-cancer therapy
PURPOSE OF THE REVIEW: Authors present the rationale, clinical development, and current status of Poly (adenosine diphospohate [ADP]) ribose polymerase (PARP) inhibitors (PARPi) as anticancer agents. RECENT FINDINGS: The recent approval of olaparib in heavily pre-treated patients with advanced ovari...
Bewaard in:
| Gepubliceerd in: | Curr Opin Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636335/ https://ncbi.nlm.nih.gov/pubmed/26447876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000238 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|